Abstract | STUDY OBJECTIVES: SETTING AND PATIENTS: RESULTS: The mean dose of cibenzoline was 70+/-12 mg. The tachycardia stopped within 6+/-3 min in 47 (81%) patients. Side effects from cibenzoline occurred in two patients. The hemodynamic complications were limited to hypotension, that required vasopressor therapy in one patient. The only apparent proarrhythmic effect consisted of an isolated change in the morphology of the VT, that resolved spontaneously on withdrawal of the drug. No mortality occurred at the hospital. CONCLUSION:
|
Authors | P Chevalier, A Dacosta, T Chalvidan, E Bonnefoy, G Kirkorian, K Isaaz, P Touboul |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 64
Issue 3
Pg. 265-70
(May 15 1998)
ISSN: 0167-5273 [Print] Netherlands |
PMID | 9672407
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Arrhythmia Agents
- Imidazoles
- cifenline
|
Topics |
- Analysis of Variance
- Anti-Arrhythmia Agents
(administration & dosage, adverse effects, therapeutic use)
- Female
- Humans
- Hypotension
(chemically induced)
- Imidazoles
(administration & dosage, adverse effects, therapeutic use)
- Infusions, Intravenous
- Male
- Middle Aged
- Prospective Studies
- Stroke Volume
- Tachycardia, Ventricular
(drug therapy, physiopathology)
|